Stanford Scientists' Findings of Virus in Lemur Could Enable AIDS Research.
HEALTH AND BEAUTY CLOSE-UP-4 December 2008-Stanford Scientists' Findings of Virus in Lemur Could Enable AIDS Research(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com The genome of a squirrel-sized, saucer-eyed lemur from Madagascar may help scientists understand how HIV-like viruses coevolved with primates, according to new research from the Stanford University...

On the front line: nurses urged to get influenza vaccination.
It's been said that "nurses are the heartbeat of the health care system." Without them, the system could not survive. Sometimes, however, in their dedication to caring for others, nurses may forget to take care of themselves. This, too, can significantly burden the healthcare system, especially when...

Flu's clues.
[ILLUSTRATION OMITTED] Ever wonder why the prime time for influenza-also known as the flu--is during the winter months? Scientists at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHHD) did. And now, they're closer to finding an answer. It seems that...

Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies.
- Patent for Antibodies that Directly Bind to Phospholipid Targets Covers All Viral Infections and All Combination Regimens - - Patent Issuance Follows Nature Medicine Publication Confirming the Broad Anti-Viral Potential of Anti-Phospholipid Approaches - TUSTIN, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. ,...

Genelabs Presents at the International Symposium on Hepatitis C Virus and Related Viruses.
HEALTH AND BEAUTY CLOSE-UP-14 October 2008-Genelabs Presents at the International Symposium on Hepatitis C Virus and Related Viruses(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Genelabs Technologies announced that three presentations were made at the 15th International Symposium on Hepatitis C Virus and Related Viruses, each on a non-nucleoside hepatitis...

Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial.
SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Vical Incorporated announced today that the company has completed enrollment of subjects in a Phase 2 trial of its therapeutic DNA vaccine designed to prevent cytomegalovirus (CMV) reactivation and disease in immunosuppressed stem cell transplant recipients. An interim analysis of immunogenicity data for...

A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks.
BOSTON, Nov. 12 /PRNewswire/ -- WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" -- often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predictions of...

Flu on you!
The flu virus is tiny, but boy, is it powerful! The virus, which can only be seen with a microscope, attacks cells in the nose, throat, and lungs. It replicates, or multiplies, quickly. It also constantly changes its shape. "That's what makes the flu so tricky," says Anthony Fiore,...

Polio transmission remains a concern.
While some countries are making substantial progress in reducing the transmission of wild polio virus, importations in other countries are occurring because of a failure to interrupt transmission in endemic countries such as Nigeria and India. A study in the Sept. 5 Morbidity and Mortality Weekly Report...

The IMF Recognizes Nobel Prize Winner.
HEALTH AND BEAUTY CLOSE-UP-13 October 2008-The IMF Recognizes Nobel Prize Winner(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - congratulated French researcher Dr. Luc Montagnier as co-recipient of the...